Lutogest SR 200 Tablet contains 200 mg of natural micronized progesterone, a bioidentical hormone essential for regulating the menstrual cycle and maintaining pregnancy. This sustained-release formulation ensures a gradual and consistent release of progesterone, optimizing therapeutic efficacy and minimizing fluctuations in hormone levels. Progesterone plays a critical role in preparing the endometrium for implantation, supporting early pregnancy, and preventing uterine contractions that may lead to miscarriage. Lutogest SR 200 is commonly prescribed for conditions such as luteal phase deficiency, amenorrhea, abnormal uterine bleeding, and as part of hormone replacement therapy in menopausal women. Additionally, it is utilized in assisted reproductive technologies to enhance implantation success rates. The natural micronized form of progesterone improves oral bioavailability and reduces the risk of adverse effects associated with synthetic progestins. Patients should adhere to prescribed dosages and consult healthcare providers regarding any contraindications, including known hypersensitivity, unexplained vaginal bleeding, or active thromboembolic disorders. Common side effects may include dizziness, headache, breast tenderness, and mild gastrointestinal disturbances. Regular monitoring is advised to assess treatment response and adjust therapy accordingly. Lutogest SR 200 Tablet offers a reliable and effective option for managing progesterone-related deficiencies and supporting reproductive health.